Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
406 Reprogramming the glioma immunosuppressive tumor microenvironment with engineered myeloid cells that release IL-2 to delay malignant progression
Compose a Response to This Article
Other responses
No responses have been published for this article.
